يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Giorgi, Dzagnidze"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

    المؤلفون: Xavier Pivot, Alexey Georgievitch Manikhas, Volodymyr Shamrai, Giorgi Dzagnidze, Hwoei Fen Soo Hoo, Viriya Kaewkangsadan, Fausto Petrelli, Cristian Villanueva, Jamie Kim, Sumita Pradhan, Litha Jaison, Peggy Feyaerts, Leonard Kaufman, Marie-Paule Derde, Filip Deforce, David G. Cox

    المصدر: BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)

    مصطلحات موضوعية: Trastuzumab, Biosimilar, HD201, Breast cancer, Neoadjuvant, HER2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1471-2407

    URL الوصول: https://doaj.org/article/6c8d15b8875948eb849c5e19e8288c4d

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial

    المؤلفون: Giorgi Dzagnidze, Justin Stebbing, Alexey Manikhas, Alexandru Eniu, Rubi K. Li, V. Baryash, Edvard Zhavrid, Joanna Pikiel, Vladimir Moiseyenko, Dmytro Boliukh, Yauheni Valerievich Baranau, Sang Joon Lee, Sunghyun Kim, Beatrice Tiangco

    المساهمون: National Institute for Health Research, Imperial College Healthcare NHS Trust- BRC Funding

    المصدر: Breast Cancer Research and Treatment

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, MULTICENTER, THERAPY, Ventricular Function, Left, 0302 clinical medicine, Trastuzumab, CYCLOPHOSPHAMIDE, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, skin and connective tissue diseases, Neoadjuvant therapy, ADJUVANT TRASTUZUMAB, DOCETAXEL, education.field_of_study, OUTCOMES, Biosimilar, HER2-positive early breast cancer, Hazard ratio, ASSOCIATION, OPEN-LABEL, Clinical Trial, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, SURVIVAL, Female, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, Population, Breast Neoplasms, Adjuvant therapy, 03 medical and health sciences, Breast cancer, Internal medicine, medicine, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, education, CT-P6, Biosimilar Pharmaceuticals, Chemotherapy, Science & Technology, business.industry, 1103 Clinical Sciences, Stroke Volume, medicine.disease, 030104 developmental biology, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939fd5615811f9b2d106c239194815fd
    http://europepmc.org/articles/PMC8272708

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  3. 3
    Efficacy and safety of tenalisib, a PI3K δ/γ and SIK3 inhibitor in patients with locally advanced or metastatic breast cancer: Initial results from a phase II study

    المؤلفون: Tamta Makharadze, Ivane Kiladze, Giorgi Dzagnidze, Nino Semionova, Lika Katselashvili, Natia Vekua, Kasi V. Routhu, Prajak J. Barde, Ajit Nair

    المصدر: Journal of Clinical Oncology. 40:1059-1059

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d41bb7a799339b847344db457cfe75c2
    https://doi.org/10.1200/jco.2022.40.16_suppl.1059

    أضف إلى المفضلة
  4. 4
    Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting

    المؤلفون: Xavier, Pivot, M A, Georgievich, Volodymyr, Shamrai, Giorgi, Dzagnidze, Hwoei Fen, Soo Hoo, Viriya, Kaewkangsadan, Fausto, Petrelli, Cristian, Villanueva, Lipatov O, Nikolaevich, Jocelyn, Hii, Jamie, Kim, Sumita, Pradhan, Litha, Jaison, Peggy, Feyaerts, Leonard, Kaufman, Marie-Paule, Derde, Ghislain M C, Bonamy, Filip, Deforce, David G, Cox

    المصدر: JAMA Oncol

    مصطلحات موضوعية: Adult, Aged, 80 and over, Cancer Research, Receptor, ErbB-2, Correction, Antineoplastic Agents, Breast Neoplasms, Middle Aged, Trastuzumab, Neoadjuvant Therapy, Oncology, Humans, Female, Aged

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e1e9f56fc5d7bd8b6a17250261ba24
    https://doi.org/10.1001/jamaoncol.2021.8171

    أضف إلى المفضلة
  5. 5
    3-year follow-up of a phase III trial comparing the efficacy and safety of neoadjuvant and adjuvant trastuzumab and its biosimilar CT-P6 in HER2 positive early breast cancer (EBC)

    المؤلفون: Daniil Stroyakovskiy, Francisco J. Esteva, Giorgi Dzagnidze, Dmytro Boliukh, Joanna Pikiel, J.H. Bae, Yauheni Valerievich Baranau, Sang Joon Lee, Vladimir Moiseyenko, S. Park, Alexey Manikhas, V. Baryash, Edvard Zhavrid, M.J. Kim, Justin Stebbing, Alexandru Eniu, Dmitry Komov, S.-B. Kim

    المصدر: Annals of Oncology. 30:v63-v64

    مصطلحات موضوعية: medicine.medical_specialty, Surrogate endpoint, business.industry, Proportional hazards model, Hazard ratio, Biosimilar, Hematology, Clinical trial, Oncology, Trastuzumab, Internal medicine, medicine, business, Epirubicin, medicine.drug, Early breast cancer

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ae43be584ca7366f4481b81e1037169f
    https://doi.org/10.1093/annonc/mdz240.016

    أضف إلى المفضلة
  6. 6
    Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial

    المؤلفون: Justin Stebbing, V. Baryash, Alexandru Eniu, Joanna Pikiel, S. Young Lee, Francisco J. Esteva, S. Yu, Yauheni Valerievich Baranau, R. K. Li, Sang Joon Lee, Daniil Stroyakovskiy, Andriy Rusyn, Dmytro Boliukh, B. Tiangco, Vladimir Moiseyenko, Giorgi Dzagnidze, Edvard Zhavrid, Alexey Manikhas

    المصدر: Cancer Chemotherapy and Pharmacology
    BASE-Bielefeld Academic Search Engine

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Toxicology, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Antineoplastic Agents, Immunological, Breast cancer, Trastuzumab, Pharmacology (medical), Pharmacology & Pharmacy, PATHOLOGICAL COMPLETE RESPONSE, Stage (cooking), skin and connective tissue diseases, Complete response, Adjuvant, Early breast cancer, ADJUVANT TRASTUZUMAB, Biosimilar, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Original Article, Drug Monitoring, 1115 Pharmacology and Pharmaceutical Sciences, Life Sciences & Biomedicine, medicine.drug, HER2 positive, medicine.medical_specialty, Breast Neoplasms, 03 medical and health sciences, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Adverse effect, CT-P6, Biosimilar Pharmaceuticals, neoplasms, Neoplasm Staging, Pharmacology, Heart Failure, Science & Technology, business.industry, medicine.disease, CONTROLLED SUPERIORITY TRIAL, 030104 developmental biology, Heart failure, business, FOLLOW-UP

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a736241d66b19d88c6d6890756b98e
    http://hdl.handle.net/10044/1/74318

    أضف إلى المفضلة
  7. 7
    Abstract OT-09-05: A randomized, pre-surgical study to investigate the biological effects of AZD9833 doses in women with ER-positive HER2-negative primary breast cancer (SERENA-3)

    المؤلفون: Andy Sykes, Richard Mather, Teresa Klinowska, Christopher J. Morrow, John F.R. Robertson, Joanna Harding, Alastair Mathewson, Li Zhang, Rhiannon Maudsley, Giorgi Dzagnidze, Andrew Saunders, Juan Enrique Bargallo Rocha, Iain K. Moppett, Justin P.O. Lindemann

    المصدر: Cancer Research. 81:OT-09

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Fulvestrant, business.industry, Estrogen receptor, Cancer, Palbociclib, medicine.disease, Breast cancer, Tolerability, Internal medicine, Pharmacodynamics, medicine, Clinical endpoint, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4f1ef461a12bc9b37df07c3b5a5f5123
    https://doi.org/10.1158/1538-7445.sabcs20-ot-09-05

    أضف إلى المفضلة
  8. 8
    Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterparts

    المؤلفون: Michaela Bartova, Giorgi Dzagnidze, Christine Staudigl, Muy-Kheng Tea, Mohamed Salama, Christian F. Singer, Zsuzsanna Bago-Horvath, Kamil Pohlodek

    المصدر: Tumor Biology. 36:3423-3428

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Poorly differentiated, Breast Neoplasms, Axillary Lymph Node Involvement, Mean age, General Medicine, Middle Aged, medicine.disease, Ki-67 Antigen, Breast cancer, Internal medicine, Overall survival, Humans, Medicine, Female, Neoplasm Metastasis, business, Ulcer, Triple-negative breast cancer, Aged

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b99e49f81702d066e564e382001aeaa2
    https://doi.org/10.1007/s13277-014-2977-7

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  9. 9
    CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

    المؤلفون: Andriy Rusyn, Vladimir Moiseyenko, Valeriy Baryash, Dmitry Komov, Dmytro Boliukh, Daniil Stroyakovskii, Sang Joon Lee, Edvard Zhavrid, Justin Stebbing, Joanna Pikiel, Giorgi Dzagnidze, Yauheni Valerievich Baranau, Sung Young Lee, Alexandru Eniu, Rubi K. Li, Gabriela Morar-Bolba, Alexey Manikhas, Francisco J. Esteva

    المساهمون: Medical Research Council (MRC), Imperial College Trust, Action Against Cancer, Breast Cancer Care & Breast Cancer Now, Cancer Research UK, Eisai Europe Ltd, Imperial College Healthcare NHS Trust- BRC Funding, Pink Ribbon Foundation, Worldwide Cancer Research, Imperial College Healthcare Charity, Wellcome Trust, National Institute for Health Research

    المصدر: The Lancet. Oncology. 18(7)

    مصطلحات موضوعية: 0301 basic medicine, Receptor, ErbB-2, medicine.medical_treatment, Docetaxel, PACLITAXEL, PLUS TRASTUZUMAB, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, PATHOLOGICAL COMPLETE RESPONSE, Neoadjuvant therapy, Mastectomy, ADJUVANT TRASTUZUMAB, education.field_of_study, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, Neoadjuvant Therapy, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Taxoids, Fluorouracil, Life Sciences & Biomedicine, medicine.drug, Epirubicin, Adult, medicine.medical_specialty, PARALLEL HER2-NEGATIVE COHORT, Population, Breast Neoplasms, BIOSIMILAR MONOCLONAL-ANTIBODIES, Adenocarcinoma, CLINICAL-TRIAL, 03 medical and health sciences, Breast cancer, Double-Blind Method, Internal medicine, medicine, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, education, Adverse effect, Biosimilar Pharmaceuticals, Cyclophosphamide, Aged, Febrile Neutropenia, Neoplasm Staging, Science & Technology, business.industry, medicine.disease, CONTROLLED SUPERIORITY TRIAL, Surgery, 030104 developmental biology, NEOADJUVANT TREATMENT, business, Febrile neutropenia

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4307529393a7a2271c09b1be158cfbe8
    https://pubmed.ncbi.nlm.nih.gov/29129095

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  10. 10
    Double-blind, randomized phase III study to compare the efficacy and safety of trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early breast cancer (EBC)

    المؤلفون: Daniil Stroyakovskiy, Sang Joon Lee, Francisco J. Esteva, V. Baryash, Edvard Zhavrid, Alexey Manikhas, Z. Zautashvili, A. Rusyn, G. Morar-Bolba, Vladimir Moiseyenko, Dmitry Komov, Giorgi Dzagnidze, Joanna Pikiel, Yauheni Valerievich Baranau, Justin Stebbing, S. Yu, Alexandru Eniu, I. Lifirenko, R. K. Li, Dmytro Boliukh

    المصدر: Annals of Oncology. 28:v44-v45

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, business.industry, Biosimilar, Hematology, Pharmacology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Biosimilar Pharmaceuticals, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, medicine, Exhaled breath condensate, business, Early breast cancer, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::41e80bafec1403cf70d1cfeb619df578
    https://doi.org/10.1093/annonc/mdx362.003

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء